Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

No reported Cost of Revenue figures are available to summarize.

Cost of Revenue history

Currency unavailable · from the income statement

No Cost of Revenue data reported for this period type.

Cost of Revenue vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
Cost of Revenue for LTGO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
COLLCollegium Pharmaceutical, Inc.LTM Mar 2026$313.15M USD+11.4%+7.6%39.3%
PCRXPacira BioSciences, Inc.LTM Mar 2026$151.86M USD-3.5%-9.1%20.7%
SCLXScilex Holding CompanyLTM Mar 2026$15.25M USD+7.1%+12.1%45.0%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding LTGO) —+7.1%+7.6%39.3%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.